Merck | MRK - Selling And Administration Expenses

Stock Price
126.40
Daily Change
-1.75 -1.37%
Monthly
-1.56%
Yearly
-7.87%
Q1 Forecast
123.95

Merck reported EUR1.46B in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Adidas EUR 2.74B 2.03B Sep/2025
Adyen EUR 141.68M 211.99M Jun/2025
Akzo Nobel EUR 811M 28M Dec/2025
Alcon AG USD 865M 5M Sep/2025
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 17.94M 17.86M Sep/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
BASF EUR 2.2B 384M Sep/2025
Bayer EUR 3.4B 140M Sep/2025
Beiersdorf EUR 322M 1.68B Jun/2025
Covestro EUR 437M 12M Sep/2025
Danone EUR 4.87B 141M Jun/2025
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
Galapagos EUR 34.55M 3.88M Sep/2025
Genmab DKK 144M 18M Jun/2025
Givaudan CHF 294.5M 229.5M Jun/2024
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Henkel EUR 3.45B 213M Jun/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Infineon EUR 409M 8M Dec/2025
Linde USD 840M 30M Sep/2025
Merck EUR 1.46B 16M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
UCB EUR 1.29B 221M Dec/2024